Lysosomal Dysfunction

The lysosome is where the cell's disposal ends. It works by being acidic — a v-ATPase proton pump holds the lumen near pH 4.5, which is the condition its hydrolases require. Lysosomal dysfunction in Alzheimer's disease is, in this corpus, overwhelmingly a failure of that acidification rather than a failure of the enzymes themselves, and the distinction is load-bearing: an under-acidified lysosome is full, not empty.

Why it is the corpus's foundational mechanism

This is the mechanism that closed the 1907–2007 loop the project was founded on. Oskar Fischer argued that senile plaques were miliary necroses — debris fields of neurons that had died from the inside out. Modern ultrastructural work identifies plaques as arising from PANTHOS neurons ("poisonous flowers"): cells engorged with undigested autophagic vacuoles because their lysosomes cannot acidify. The plaque is the tombstone of a neuron that could not finish digesting itself.

Several apparently unrelated risk factors converge here. PSEN1 mutations, HSV-1 infection, and HNE-mediated oxidation of the v-ATPase all impair acidification, which is what makes the lysosome a bottleneck rather than one pathway among many.

The specific lesion

The most direct molecular account in the corpus is v-ATPase inhibition by Tyr682-phosphorylated APP βCTF — the C99 fragment, phosphorylated, binding and inhibiting the pump (Im, Jiang, Stavrides et al., Nixon; Science Advances 2023;9(30):eadg1925). This is the same fragment that the MAM/lipid account treats as a cholesterol signal that is never switched off, which is one of the corpus's tighter convergences: two frameworks, one molecule, different faces of it.

A caution the corpus records: an earlier claim that PSEN deficiency causes endo-lysosomal dysfunction through proton-pump failure was contradicted — Coen and colleagues attribute it to lysosomal calcium homeostasis defects, not proton pump defects (J Cell Biol 2012;198(1):23–35). The mechanism is therefore not uniform across causes.

Where it sits in time

Shokhirev's multi-omics stratification places Proteostasis and energy metabolism as the earliest impaired hallmarks in patients under 75, with immune activation and cell death later. Lysosomal failure is the concrete form the proteostatic stratum takes, which is why the corpus reads it as Phase II's engine rather than as a late consequence.

What could be done about it

The therapeutic reading is unusually specific, and it comes with an ordering constraint the corpus states plainly as "re-acidify before you induce." Inducing autophagy into a lysosome that cannot digest only adds to the load. Candidate approaches named: v-ATPase assembly enhancers, TRPML1 agonists driving lysosomal calcium signalling and downstream biogenesis, and TFEB activators driving the transcriptional programme for lysosomal renewal. A separate line arrives at the same pump from the immune side — a glycolytic switch recruiting Aldolase A to scaffold v-ATPase reassembly, restoring acidification and autophagic flux.

Related

Autophagic Flux · Proteostasis · Endolysosomal Dysfunction · Autophagy Dysfunction · Energy Metabolism · Endosomal Nexus · Bioenergetic Collapse